Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peter C. Rüegg
Observed names:
P C Ruegg,
Peter C. Ruegg,
Peter Ruegg,
Peter Rüegg
Institution:
Novartis (Germany)
Observed institutions:
Novartis (Switzerland),
Novartis (Germany),
Kantonsspital Winterthur,
Spital Limmattal,
Sandoz Group AG (Switzerland)
OpenAlex ID:
A5113562877
Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects
2002
·
Joel Morganroth
, Peter C. Ruegg
, et al.
·
The American Journal of Gastroenterology
·
70
Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms
2002
·
James Fidelholtz
, William Smith
, et al.
·
The American Journal of Gastroenterology
·
37
A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension
1989
·
Carl-David Sundstedt
, Peter C. Rüegg
, et al.
·
The American Journal of Medicine
·
26
Tegaserod: Long-Term Treatment for Irritable Bowel Syndrome Patients with Constipation in Primary Care
2005
·
Peter Layer
, Jutta Keller
, et al.
·
Digestion
·
22
Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside.
1992
·
P C Ruegg
, D David
, et al.
·
PubMed
·
15
Cardiac electrophysiologic properties of intravenous isradipine in patients with sick sinus syndrome
1989
·
Leen M. van Wijk
, Isabel van Gelder
, et al.
·
The American Journal of Medicine
·
8
Safety and efficacy of isradipine, alone and in combination, in the treatment of angina pectoris
1989
·
Peter C. Rüegg
, David J. Nelson
·
The American Journal of Medicine
·
8
Management of Perioperative Hypertension Using Intravenous Isradipine
1991
·
Peter C. Rüegg
, Urs Karmann
, et al.
·
American Journal of Hypertension
·
7
Hemodynamic effects of an intravenous infusion of isradipine in patients with congestive heart failure
1988
·
E.Wout van den Toren
, Auke van Bruggen
, et al.
·
The American Journal of Medicine
·
7
Tegaserod Significantly Reduces Work Productivity Loss and Daily Activity Impairment in Patients With Ibs With Constipation
2004
·
Margaret C Reilly
, Victoria Barghout
, et al.
·
The American Journal of Gastroenterology
·
5
DPI 201–106
1987
·
Günter Scholtysik
, Peter Rüegg
·
Cardiovascular Drug Reviews
·
1
Show more works
View as search
Works count:
11
Citation count:
205
H-index:
7
I10-index:
5
Year
Topic
Type